Recent Finacing
Recent Raise
Perseo pharma AG is a Basel spin‑off developing therapeutic enzymes for cancer and rare genetic diseases using Inofea's enzzen platform that immobilizes enzymes on silica with nano‑shields enhancing stability.
Focus Areas
Recent Investors
Funding round
Investors
See the team members at Perseo pharma.
